AMA Journal of Ethics^®

Dr Aysha Akhtar joins Ethics Talk to discuss her article, coauthored with Mikalah Singer, “With What Should We Replace Nonhuman Animals in Biomedical Research Protocols?”

Historically, most discussions about nonhuman animal experimentation consider what has become known as the 3 R’s: refinement, reduction, and replacement.

Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality.

Dr Ellen L. Edens joins Ethics Talk to discuss her article, coauthored with Drs Gabriela Garcia Vassallo and Robert Heimer: "How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice?”

Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions.

Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD.

Dr Elizabeth Salisbury-Afshar joins Ethics Talk to discuss her article, coauthored with Drs Catherine J. Livingston and Ricky N. Bluthenthal: “How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder?”

Dr Donald Egan joins Ethics Talk to discuss his article, coauthored with Drs Adriane M. dela Cruz, Sarah E. Baker, and John Z. Sadler: “When Are ‘Paraphernalia’ Critical Medical Supplies?”

Dr Jim Withers and Dave Lettrich join Ethics talk to discuss how street outreach programs help mitigate harms of drug use among people experiencing homelessness.

Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities.